EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Prevention and Management of Driveline Infections in Ventricular Assist Device Patients: The DESTINE 2.0 Staging Proposal and Expert Recommendations

Alexander M Bernhardt iD, Volker Lauenroth, Florian Mueller, Friedrich Kaufmann iD, Katharina Homann, Martina Socha, Thomas Schlöglhofer iD, Driveline Expert STagINg and carE (DESTINE) study group

Artificial Organs · 2026-11 · 50 (11) · 1546-1563

DOI: 10.1111/aor.70237 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Artificial Organs, online erschienen am 09.09.2026. Verfasst von Alexander M Bernhardt und 7 weiteren Autor:innen. Beteiligte Einrichtung: Department of Cardiac Surgery, University Heart and Vascular Center Hamburg, University Hospital Hamburg-Eppendorf, Hamburg, Germany. Hauptthemen laut MEDLINE: Heart-Assist Devices, Prosthesis-Related Infections. Die Arbeit nennt 97 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Driveline infections (DLIs) remain the predominant device‐specific complication in patients supported by left ventricular assist devices (LVADs) serving as a major source of morbidity, recurrent hospitalization, and mortality. Despite their clinical impact, the prevention and early management of DLIs lack standardization, particularly within outpatient and home‐based care environments. Methods and Objectives The original 2020 DESTINE proposal introduced a standardized dressing protocol and a prevention‐oriented staging system for driveline exit‐site management. However, subsequent clinical real‐world experience revealed limitations, including overly complex early‐stage subcategorization and the absence of contemporary guidance on wound care, including fixation strategies, antiseptic agents, and adjunctive therapies. Updated Recommendations DESTINE 2.0 provides expert recommendations to address these gaps. The updated framework features a streamlined five‐stage system that consolidates previous subcategories into unambiguous, actionable clinical stages. Enhanced recommendations are provided for driveline immobilization, stage‐stratified antiseptic agent selection, and skin barrier preservation. Furthermore, the protocol incorporates adjunctive therapies including cold atmospheric plasma and closed‐incision negative pressure wound therapy. Expanded guidance covers modifiable patient‐level risk factors, perioperative prophylaxis, showering safety, caregiver education, digital documentation, and stage‐directed antibiotic therapy.

Conclusion

By providing a practical, integrated framework applicable to multidisciplinary care settings, DESTINE 2.0 aims to optimize infection‐free survival, minimize healthcare utilization, and improve quality of life for patients on long‐term mechanical circulatory support.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Heart-Assist DevicesProsthesis-Related InfectionsHumansRisk Factors

Stichwörter der Autor:innen

DESTINE stagingdriveline infectionleft ventricular assist devicepreventionrevalidationstandard operating procedure

Autor:innen und Institutionen

  • Department of Cardiac Surgery, University Heart and Vascular Center Hamburg, University Hospital Hamburg-Eppendorf, Hamburg, Germany.
  • Department for Thoracic- and Cardiovascular Surgery, Heart & Diabetes Center, North Rhine-Westphalia, Bad Oeynhausen, Germany.
  • Klinik für Innere Medizin III (Kardiologie, Angiologie Und Internistische Intensivmedizin), Universitätsklinikum Des Saarlandes, Saarland University, Homburg, Germany.
  • Department of Cardiothoracic and Vascular Surgery, Deutsches Herzzentrum der Charite, Berlin, Germany.
  • Department of Cardiothoracic, Transplantation and Vascular Surgery, Hannover Medical School, Hannover, Germany.
  • Center for Medical Physics and Biomedical Engineering, Department of Cardiac and Thoracic Aortic Surgery, Medical University of Vienna, Vienna, Austria.

ORCID-Profile: Alexander M Bernhardt, Friedrich Kaufmann, Thomas Schlöglhofer

Zitieren

APA

Bernhardt, A. M., Lauenroth, V., Mueller, F., Kaufmann, F., Homann, K., Socha, M., Schlöglhofer, T., & Driveline Expert STagINg and carE (DESTINE) study group (2026). Prevention and Management of Driveline Infections in Ventricular Assist Device Patients: The DESTINE 2.0 Staging Proposal and Expert Recommendations. Artificial Organs, 50(11), 1546-1563. https://doi.org/10.1111/aor.70237

Vancouver

Bernhardt AM, Lauenroth V, Mueller F, Kaufmann F, Homann K, Socha M, et al. Prevention and Management of Driveline Infections in Ventricular Assist Device Patients: The DESTINE 2.0 Staging Proposal and Expert Recommendations. Artificial Organs. 2026;50(11):1546-1563. doi:10.1111/aor.70237

BibTeX
@article{Bernhardt2026,
  author = {Bernhardt, Alexander M and Lauenroth, Volker and Mueller, Florian and Kaufmann, Friedrich and Homann, Katharina and Socha, Martina and Schlöglhofer, Thomas and Driveline Expert STagINg and carE (DESTINE) study group, Driveline Expert STagINg and carE (DESTINE) study group},
  title = {Prevention and Management of Driveline Infections in Ventricular Assist Device Patients: The DESTINE 2.0 Staging Proposal and Expert Recommendations},
  journal = {Artificial Organs},
  year = {2026},
  volume = {50},
  number = {11},
  pages = {1546--1563},
  doi = {10.1111/aor.70237}
}
Kostenlos starten →